BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 17938211)

  • 1. Noncatalytic role of the FKBP52 peptidyl-prolyl isomerase domain in the regulation of steroid hormone signaling.
    Riggs DL; Cox MB; Tardif HL; Hessling M; Buchner J; Smith DF
    Mol Cell Biol; 2007 Dec; 27(24):8658-69. PubMed ID: 17938211
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The helix 1-3 loop in the glucocorticoid receptor LBD is a regulatory element for FKBP cochaperones.
    Cluning C; Ward BK; Rea SL; Arulpragasam A; Fuller PJ; Ratajczak T
    Mol Endocrinol; 2013 Jul; 27(7):1020-35. PubMed ID: 23686112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FK506-binding protein 52 phosphorylation: a potential mechanism for regulating steroid hormone receptor activity.
    Cox MB; Riggs DL; Hessling M; Schumacher F; Buchner J; Smith DF
    Mol Endocrinol; 2007 Dec; 21(12):2956-67. PubMed ID: 17717070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential conformational dynamics in the closely homologous FK506-binding domains of FKBP51 and FKBP52.
    Mustafi SM; LeMaster DM; Hernández G
    Biochem J; 2014 Jul; 461(1):115-23. PubMed ID: 24749623
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coupling of Conformational Transitions in the N-terminal Domain of the 51-kDa FK506-binding Protein (FKBP51) Near Its Site of Interaction with the Steroid Receptor Proteins.
    LeMaster DM; Mustafi SM; Brecher M; Zhang J; Héroux A; Li H; Hernández G
    J Biol Chem; 2015 Jun; 290(25):15746-15757. PubMed ID: 25953903
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional Comparison of Human and Zebra Fish FKBP52 Confirms the Importance of the Proline-Rich Loop for Regulation of Steroid Hormone Receptor Activity.
    Harris DC; Garcia YA; Samaniego CS; Rowlett VW; Ortiz NR; Payan AN; Maehigashi T; Cox MB
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31661769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural characterization of the PPIase domain of FKBP51, a cochaperone of human Hsp90.
    Bracher A; Kozany C; Thost AK; Hausch F
    Acta Crystallogr D Biol Crystallogr; 2011 Jun; 67(Pt 6):549-59. PubMed ID: 21636895
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Hsp90-binding peptidylprolyl isomerase FKBP52 potentiates glucocorticoid signaling in vivo.
    Riggs DL; Roberts PJ; Chirillo SC; Cheung-Flynn J; Prapapanich V; Ratajczak T; Gaber R; Picard D; Smith DF
    EMBO J; 2003 Mar; 22(5):1158-67. PubMed ID: 12606580
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Crystal structures of the free and ligand-bound FK1-FK2 domain segment of FKBP52 reveal a flexible inter-domain hinge.
    Bracher A; Kozany C; Hähle A; Wild P; Zacharias M; Hausch F
    J Mol Biol; 2013 Nov; 425(22):4134-44. PubMed ID: 23933011
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Analysis of FKBP51/FKBP52 chimeras and mutants for Hsp90 binding and association with progesterone receptor complexes.
    Barent RL; Nair SC; Carr DC; Ruan Y; Rimerman RA; Fulton J; Zhang Y; Smith DF
    Mol Endocrinol; 1998 Mar; 12(3):342-54. PubMed ID: 9514152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. NF-κB transcriptional activity is modulated by FK506-binding proteins FKBP51 and FKBP52: a role for peptidyl-prolyl isomerase activity.
    Erlejman AG; De Leo SA; Mazaira GI; Molinari AM; Camisay MF; Fontana V; Cox MB; Piwien-Pilipuk G; Galigniana MD
    J Biol Chem; 2014 Sep; 289(38):26263-26276. PubMed ID: 25104352
    [TBL] [Abstract][Full Text] [Related]  

  • 12. FK506-binding proteins 51 and 52 differentially regulate dynein interaction and nuclear translocation of the glucocorticoid receptor in mammalian cells.
    Wochnik GM; Rüegg J; Abel GA; Schmidt U; Holsboer F; Rein T
    J Biol Chem; 2005 Feb; 280(6):4609-16. PubMed ID: 15591061
    [TBL] [Abstract][Full Text] [Related]  

  • 13. FKBP51 and FKBP52 in signaling and disease.
    Storer CL; Dickey CA; Galigniana MD; Rein T; Cox MB
    Trends Endocrinol Metab; 2011 Dec; 22(12):481-90. PubMed ID: 21889356
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A β-Turn Motif in the Steroid Hormone Receptor's Ligand-Binding Domains Interacts with the Peptidyl-prolyl Isomerase (PPIase) Catalytic Site of the Immunophilin FKBP52.
    Byrne C; Henen MA; Belnou M; Cantrelle FX; Kamah A; Qi H; Giustiniani J; Chambraud B; Baulieu EE; Lippens G; Landrieu I; Jacquot Y
    Biochemistry; 2016 Sep; 55(38):5366-76. PubMed ID: 27641460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional analysis of the Hsp90-associated human peptidyl prolyl cis/trans isomerases FKBP51, FKBP52 and Cyp40.
    Pirkl F; Buchner J
    J Mol Biol; 2001 May; 308(4):795-806. PubMed ID: 11350175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Targeting of the FKBP52 Co-Chaperone in Steroid Hormone Receptor-Regulated Physiology and Disease.
    Guy NC; Garcia YA; Cox MB
    Curr Mol Pharmacol; 2015; 9(2):109-25. PubMed ID: 25986565
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular dynamics simulation, binding free energy calculation and unbinding pathway analysis on selectivity difference between FKBP51 and FKBP52: Insight into the molecular mechanism of isoform selectivity.
    Shi D; Bai Q; Zhou S; Liu X; Liu H; Yao X
    Proteins; 2018 Jan; 86(1):43-56. PubMed ID: 29023988
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C-terminal sequences outside the tetratricopeptide repeat domain of FKBP51 and FKBP52 cause differential binding to Hsp90.
    Cheung-Flynn J; Roberts PJ; Riggs DL; Smith DF
    J Biol Chem; 2003 May; 278(19):17388-94. PubMed ID: 12611898
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Structure of the N-terminal domain of human FKBP52.
    Li P; Ding Y; Wu B; Shu C; Shen B; Rao Z
    Acta Crystallogr D Biol Crystallogr; 2003 Jan; 59(Pt 1):16-22. PubMed ID: 12499534
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FKBP51 and FKBP52 regulate androgen receptor dimerization and proliferation in prostate cancer cells.
    Maeda K; Habara M; Kawaguchi M; Matsumoto H; Hanaki S; Masaki T; Sato Y; Matsuyama H; Kunieda K; Nakagawa H; Shimada M
    Mol Oncol; 2022 Feb; 16(4):940-956. PubMed ID: 34057812
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.